Cantabio Pharmaceuticals, Inc. operates as a pre-clinical drug development company focused on developing therapeutics for neurodegenerative and metabolic diseases. The company develops drug candidates ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings with ...

Cantabio Pharmaceuticals, Inc. (CTBO) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends ...

Find the latest Cantabio Pharmaceuticals, Inc. (CTBO) stock quote, history, news and other vital information to help you with your stock trading and investing.

At close: 7 October at 4:00 pm GMT-4 ...

As of February 4 at 4:00:00 p.m. EST. Market Open.

Research reports are not currently available for CTBO.

At close: 24 December at 16:00:00 GMT-5 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.